Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection

Phase 4 Terminated 7 enrolled RWTH Aachen University Hannover Medical School · collab

NaSingle-groupOpen-label

Summary

This study will examine whether 12 month treatment with entecavir(Baraclude®) has an effect on changes of liver stiffness measurement (LSM) and of hyaluronan measurement in patients with chronic hepatitis B infection.

Timeline

Start: 2011-04
Primary completion: 2015-01
Completion: 2015-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Entecavir	Small molecule	—	Oral

Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection

Summary

Timeline

Drugs

Indications